Last updated: May 4, 2025
Sponsor: Nikola Janovska
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vaginal Cancer
Human Papilloma Virus (Hpv)
Dysfunctional Uterine Bleeding
Treatment
N/AClinical Study ID
NCT06967740
EKVP/51/2024
Ages 18-46 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Informed Consent
cervical biopsy - HG lesion
Age: 18-46 years
colposcopicaly visible transformation zone
HPV: Unvaccinated
cytology all except AIS, adenocarcinoma, squamous cell carcinoma, AGC NEO
Exclusion
Exclusion Criteria:
cytology AIS, AGC NEO, adenocarcinoma, squamous cell carcinoma
immunosuppression
active autoimmune disease
history of cervical cryodestruction
HPV vaccinated prior to start of the study
Study Design
Total Participants: 200
Study Start date:
November 01, 2024
Estimated Completion Date:
December 31, 2029
Connect with a study center
University Hospital Kralovske Vinohrady
Prague, 10034
Czech RepublicActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.